Navigation Links
Ophthalmic Devices Market Analysis for Greece, Poland, Hungary & Ireland 2018 Forecasts in New Research Report at RnRMarketResearch.com
Date:8/17/2013

Dallas, Texas (PRWEB) August 17, 2013

These new reports provides key market data on the Greece, Poland, Hungary & Ireland Ophthalmic Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Vision Care, Intraocular Lens (IOL) ,Refractive Surgery Devices, Ophthalmic Diagnostic Equipment, Vitreo Retinal Surgery Devices, Cataract Surgery Devices and Glaucoma Surgery Devices. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Get a copy of Greece Ophthalmic Devices Market report @ http://www.rnrmarketresearch.com/greece-ophthalmic-devices-investment-opportunities-analysis-and-forecasts-to-2018-market-report.html.

Scope
Market size and company share data for Ophthalmic Devices market categories – Vision Care, Intraocular Lens (IOL) ,Refractive Surgery Devices, Ophthalmic Diagnostic Equipment, Vitreo Retinal Surgery Devices, Cataract Surgery Devices and Glaucoma Surgery Devices.
Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
2011 company shares and distribution shares data for each of the seven market categories.
Global corporate-level profiles of key companies operating within the Greece Ophthalmic Devices market.
Key players covered include Essilor International, Carl Zeiss AG, CIBA Vision Corporation, Alcon, Inc., Johnson & Johnson Vision Care, Inc., Bausch & Lomb Incorporated, CooperVision, Inc., Hoya Corporation , Abbott Medical Optics, Inc., Topcon Corporation and Others.

Get a copy of Poland Ophthalmic Devices Market report @ http://www.rnrmarketresearch.com/poland-ophthalmic-devices-investment-opportunities-analysis-and-forecasts-to-2018-market-report.html.

Reasons to buy
Develop business strategies by identifying the key market categories and segments poised for strong growth.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the Greece, Poland, Hungary & Ireland Ophthalmic Devices competitive landscape.
Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Get a copy of Hungary Ophthalmic Devices Market report @ http://www.rnrmarketresearch.com/hungary-ophthalmic-devices-investment-opportunities-analysis-and-forecasts-to-2018-market-report.html.

Table of Contents
4 Cataract Surgery Devices In Greece 22
4.1 Cataract Surgery Devices Overall Revenue, (2004-2018)
4.1.1 Ophthalmic Viscoelastic Devices (OVD), Revenue (2004-2018)
4.2 Cataract Surgery Devices Overall Volume (2004-2018)
4.2.1 Ophthalmic Viscoelastic Devices (OVD), Volume (2004-2018)
4.3 Cataract Surgery Devices Average Price (2004-2018)
4.4 Cataract Surgery Devices Distribution Share (2010-2011)
4.5 Cataract Surgery Devices, Greece, Poland, Hungary & Ireland, Company Share (2010-2011)

5 Glaucoma Surgery Devices In Greece 38
5.1 Glaucoma Surgery Devices Overall Revenue, (2004-2018)
5.2 Glaucoma Surgery Devices Overall Volume (2004-2018)
5.3 Glaucoma Surgery Devices Average Price (2004-2018)
5.4 Glaucoma Surgery Devices Distribution Share (2010-2011)
5.5 Glaucoma Surgery Devices, Greece, Poland, Hungary & Ireland, Company Share (2010-2011)

6 Intraocular Lens (IOL) In Greece 46
6.1 Intraocular Lens (IOL) Overall Revenue, (2004-2018)
6.1.1 Foldable IOL, Revenue, (2004-2018)
6.2 Intraocular Lens (IOL) Overall Volume (2004-2018)
6.2.1 Foldable IOL, Volume (2004-2018)
6.3 Intraocular Lens (IOL) Average Price (2004-2018)
6.4 Intraocular Lens (IOL) Distribution Share (2010-2011)
6.5 Intraocular Lens (IOL), Greece, Poland, Hungary & Ireland, Company Share (2010-2011)

Get a copy of Ireland Ophthalmic Devices Market report @ http://www.rnrmarketresearch.com/ireland-ophthalmic-devices-investment-opportunities-analysis-and-forecasts-to-2018-market-report.html.

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/ophthalmic-devices-market/analysis-and-forecasts/prweb11034493.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Forum to bring together leading-edge ophthalmic researchers and investors
2. Paragon BioTeck, Inc. Announces FDA Approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%
3. FDA Gives 510k Clearance to EyeKor’s EXCELSIOR™ Cloud-based Image Management Software for Ophthalmic Clinical Trials
4. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
5. Oakworks Medical, a Division of Oakworks Inc., Oakworks.com, Manufacturer of Medical Tables and Positioning Devices Announces ISO 13485 Certification
6. Adena Delivers Instant Health Information to Mobile Devices
7. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
8. Magnets in iPad2 May Alter Settings on Brain Shunt Devices: Study
9. Cell-Based Tracking Devices Might Help Monitor Treatments
10. Study: Clot removal devices successful tools for acute ischemic stroke treatment
11. OU research team developing robotic devices to aid infants with cerebral palsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 , ... RawTrition now brings ... way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients to ... cellular level because the body recognizes its raw form (unlike the synthetically made options ...
(Date:4/26/2017)... ... April 26, 2017 , ... MYOLYN, ... to announce that it has received 510(k) clearance from the U.S. Food & ... the MyoCycle Pro. , Both devices are stationary cycling systems that use MYOLYN’s ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition Duchenne, ... Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on ... clinical trial in Duchenne announced today. , Coalition Duchenne funded studies carried ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... unveiling cutting-edge birth defects research related to Zika virus during pregnancy, as well ... society for this important science. , The Teratology Society is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology: